Prescient Therapeutics Limited (ASX:PTX)
Australia
· Delayed Price · Currency is AUD 0.0510
0.00 (0.00%)
Apr 29, 2026, 4:10 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 53.63 million as of April 28, 2026. Its market cap has increased by 70.75% in one year.
Market Cap
53.63M
Enterprise Value
44.13M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 53.63M, an increase of 836.80%. That is a compound annual growth rate of 8.27%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 56.30M |
| Neurizon Therapeutics | 62.34M |
| Radiopharm Theranostics | 74.43M |
| Proteomics International Laboratories | 43.77M |
| LTR Pharma | 78.16M |
| Imugene | 41.06M |
| Cynata Therapeutics | 80.73M |
| Avecho Biotechnology | 40.41M |